On August 28th, Gelonhui reported its 2024 interim report, with a half-yearly revenue of 1.066 billion yuan, a year-on-year increase of 3.22%; the net income attributable to the shareholders of the listed company was 91.0206 million yuan, a year-on-year increase of 1.86%; the net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 84.9487 million yuan, a year-on-year increase of 2.14%; and the basic earnings per share was 0.1166 yuan.
金河生物(002688.SZ)：上半年净利润9102.06万元 同比增长1.86%
Jinhe Biotechnology (002688.SZ): Net income in the first half of the year was 91.0206 million yuan, a year-on-year increase of 1.86%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated